echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > WHO: Existing new crown vaccines need to be updated to deal with future mutant strains

    WHO: Existing new crown vaccines need to be updated to deal with future mutant strains

    • Last Update: 2022-01-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The World Health Organization issued a statement on the 11th saying that the new crown vaccine that has been certified by WHO for emergency use is still effective against the Omicron strain, but the existing new crown vaccine may need to be updated to continue to provide people with sufficient protection.
    Responding to current and future mutated coronaviruses
    .
     
    Experts from the WHO's new crown vaccine composition technical advisory group are currently analyzing evidence related to the "required concern" variant strains, and may revise the recommendations for new crown vaccine strain components accordingly, the statement said
    .
    According to the transmissibility and pathogenicity of the mutated new coronavirus, the WHO has classified the mutated strains as "requiring attention" or "requiring attention", among which Omicron and Delta are all mutant viruses that "require attention" strains
    .
     
    The WHO's new crown vaccine composition technical advisory group was established in September last year and consists of 18 experts from different disciplines
    .
    The expert group issued an interim statement on the 11th, saying that the new crown vaccine that has been certified for emergency use by the WHO is still effective against the mutant strains that "required attention" such as Omicron, especially for the severe disease and death of the new crown.
    protection
    .
    But at the same time, experts also emphasized the need to develop vaccines that can better prevent the infection and spread of the new coronavirus in the future
    .
     
      In addition, as the new coronavirus mutates, the components of the existing new crown vaccine may also need to be updated to ensure that the infection and Continue to provide the WHO-recommended level of protection in the event of illness
    .
     
      Specifically, the updated vaccine strain components need to be genetically and antigenically similar to the circulating mutant virus, be more effective in preventing infection, and elicit a "broad, strong and durable" immune response to "reduce the risk of Need for continuous reinforcement needles"
    .
     
      WHO has also proposed a number of options for updating the programme, including the development of monovalent vaccines against the main circulating variant strains, multivalent vaccines containing antigens from multiple variant strains that "require attention", or the development of more sustained, multivalent vaccines targeting different variants.
    A long-term vaccine for which the strain remains effective
    .
     
      In response to the Omicron strain currently circulating in many countries, the expert group calls for a wider global promotion of full vaccination and booster programs, hoping to help reduce the emergence of new "requiring attention" mutant strains and reduce its hazards
    .
      The World Health Organization issued a statement on the 11th saying that the new crown vaccine that has been certified by WHO for emergency use is still effective against the Omicron strain, but the existing new crown vaccine may need to be updated to continue to provide people with sufficient protection.
    Responding to current and future mutated coronaviruses
    .
     
      Experts from the WHO's new crown vaccine composition technical advisory group are currently analyzing evidence related to the "required concern" variant strains, and may revise the recommendations for new crown vaccine strain components accordingly, the statement said
    .
    According to the transmissibility and pathogenicity of the mutated new coronavirus, the WHO has classified the mutated strains as "requiring attention" or "requiring attention", among which Omicron and Delta are all mutant viruses that "require attention" strains
    .
     
      The WHO's new crown vaccine composition technical advisory group was established in September last year and consists of 18 experts from different disciplines
    .
    The expert group issued an interim statement on the 11th, saying that the new crown vaccine that has been certified for emergency use by the WHO is still effective against the mutant strains that "required attention" such as Omicron, especially for the severe disease and death of the new crown.
    protection
    .
    But at the same time, experts also emphasized the need to develop vaccines that can better prevent the infection and spread of the new coronavirus in the future
    .
     
      In addition, as the new coronavirus mutates, the components of the existing new crown vaccine may also need to be updated to ensure that the infection and Continue to provide the WHO-recommended level of protection in the event of illness
    .
     
      Specifically, the updated vaccine strain components need to be genetically and antigenically similar to the circulating mutant virus, be more effective in preventing infection, and elicit a "broad, strong and durable" immune response to "reduce the risk of Need for continuous reinforcement needles"
    .
     
      WHO has also proposed a number of options for updating the programme, including the development of monovalent vaccines against the main circulating variant strains, multivalent vaccines containing antigens from multiple variant strains that "require attention", or the development of more sustained, multivalent vaccines targeting different variants.
    A long-term vaccine for which the strain remains effective
    .
     
      In response to the Omicron strain currently circulating in many countries, the expert group calls for a wider global promotion of full vaccination and booster programs, hoping to help reduce the emergence of new "requiring attention" mutant strains and reduce its hazards
    .
      The World Health Organization issued a statement on the 11th saying that the new crown vaccine that has been certified by WHO for emergency use is still effective against the Omicron strain, but the existing new crown vaccine may need to be updated to continue to provide people with sufficient protection.
    Responding to current and future mutated coronaviruses
    .
     
      Experts from the WHO's new crown vaccine composition technical advisory group are currently analyzing evidence related to the "required concern" variant strains, and may revise the recommendations for new crown vaccine strain components accordingly, the statement said
    .
    According to the transmissibility and pathogenicity of the mutated new coronavirus, the WHO has classified the mutated strains as "requiring attention" or "requiring attention", among which Omicron and Delta are all mutant viruses that "require attention" strains
    .
     
      The WHO's new crown vaccine composition technical advisory group was established in September last year and consists of 18 experts from different disciplines
    .
    The expert group issued an interim statement on the 11th, saying that the new crown vaccine that has been certified for emergency use by the WHO is still effective against the mutant strains that "required attention" such as Omicron, especially for the severe disease and death of the new crown.
    protection
    .
    But at the same time, experts also emphasized the need to develop vaccines that can better prevent the infection and spread of the new coronavirus in the future
    .
     
      In addition, as the new coronavirus mutates, the components of the existing new crown vaccine may also need to be updated to ensure that the infection and Continue to provide the WHO-recommended level of protection in the event of illness
    .
    disease disease disease
     
      Specifically, the updated vaccine strain components need to be genetically and antigenically similar to the circulating mutant virus, be more effective in preventing infection, and elicit a "broad, strong and durable" immune response to "reduce the risk of Need for continuous reinforcement needles"
    .
     
      WHO has also proposed a number of options for updating the programme, including the development of monovalent vaccines against the main circulating variant strains, multivalent vaccines containing antigens from multiple variant strains that "require attention", or the development of more sustained, multivalent vaccines targeting different variants.
    A long-term vaccine for which the strain remains effective
    .
     
      In response to the Omicron strain currently circulating in many countries, the expert group calls for a wider global promotion of full vaccination and booster programs, hoping to help reduce the emergence of new "requiring attention" mutant strains and reduce its hazards
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.